Price Alert

Outset Medical Inc. (OM)

NASDAQ: OM · Real-Time Price · USD

13.56

0.21 (1.57%)

At close: Sep 05, 2025, 11:29 AM

1.57% (1D)

Bid	13.51
Market Cap	241M
Revenue (ttm)	119.3M
Net Income (ttm)	-97.9M
EPS (ttm)	-18.19
PE Ratio (ttm)	-0.75
Forward PE	-5.3
Analyst	Hold

Ask	13.61
Volume	19,122
Avg. Volume (20D)	362,667
Open	13.43
Previous Close	13.35
Day's Range	13.22 - 13.75
52-Week Range	5.85 - 25.35
Beta	2.14

About OM

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol OM

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for OM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Outset Medical Inc. is scheduled to release its earnings on Nov 5, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

4 weeks ago

+7.67%

Outset Medical shares are trading higher after the... Unlock content with Pro Subscription

4 weeks ago

-6.6%

Outset Medical shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 sales guidance with its midpoint above estimates.

News

2 weeks ago · zacks.com

After Plunging 26.8% in 4 Weeks, Here's Why the Trend Might Reverse for Outset Medical (OM)

Outset Medical (OM) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estima...

3 weeks ago · benzinga.com

Top 3 Health Care Stocks That Are Preparing To Pump This Month

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

4 weeks ago · seekingalpha.com

Outset Medical, Inc. (OM) Q2 2025 Earnings Call Transcript

Outset Medical, Inc. (NASDAQ:OM ) Q2 2025 Earnings Conference Call August 6, 2025 5:00 PM ET Company Participants James S. Mazzola - Head of Investor Relations Leslie L.

4 weeks ago · zacks.com

Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates

Outset Medical, Inc. (OM) came out with a quarterly loss of $0.84 per share versus the Zacks Consensus Estimate of a loss of $1.76. This compares to a loss of $7.05 per share a year ago.

2 months ago · seekingalpha.com

Why Outset Medical's Rock-Bottom Valuation Masks Explosive Growth

The company's business model leverages recurring revenue streams and strong customer retention, supporting stable long-term growth. Key risks include potential regulatory changes and execution challen...

2 months ago · zacks.com

Strength Seen in Outset Medical (OM): Can Its 15.0% Jump Turn into More Strength?

Outset Medical (OM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term...